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Wild typein the TNFRp55/ mice after 15 weeks infection. These results show that in the absence of
TNFRp55, L. (L.) amazonensis-infected knockout mice fail to resolve lesions, whereas wild-
type mice completely heal.
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reserved.Leishmaniasis, a parasitic disease caused by protozoa of the
genus Leishmania, is an important endemic disease
affecting > 12 million people worldwide. Different species
of Leishmania cause disease in different areas of the world.
Cutaneous leishmaniasis may be caused by Leishmania
(Leishmania) major in the Old World and by Leishmania (L.)
amazonensis or Leishmania (Viannia) braziliensis in the
New World, including Argentina.1
It has been determined that different Leishmania spe-
cies elicit distinctive patterns of the immune response in
animal models. This can be illustrated by the different
susceptibility of CBA mice, which are known to be resistant
to L. (L.) major but susceptible to L. (L.) amazonensis
infection. Infection of CBA mice with L. (L.) major gener-
ates interferon (IFN)-g, which is sufficient to prevent the
development of a T helper (Th)2 response and to induce
instead a protective Th1 immune response. On the con-
trary, CBA mice produce high levels of interleukin-4 but
they do not produce significant amounts of IFN-g after
infection with L. (L.) amazonensis. The lack of IFN-g biases
the immune response towards a Th2 profile.2
The effect of tumor necrosis factor (TNF) in the outcome
of Leishmania infection has been more thoroughly studied
in C57BL/6 (B6) mice deficient in the TNF receptor (TNFR)
p55 (TNFRp55/) and TNFRp75 (TNFRp75/) compared
with the wild-type (WT) mice of the same genetic back-
ground3,4 and in mice deficient in the production of soluble
TNF infected with L. (L.) major.5
Vieira et al5 have demonstrated that both TNFRp55/
and WT mice develop a normal Th1 type response and are
able to eliminate parasites in vivo during L. (L.) major
infection. These results demonstrate that the macrophage
microbicidal activity is not dependent on the p55 receptor
for TNF; however, TNFRp55/ mice develop larger lesions.
In another experimental model, B6 knockout (KO) mice
infected with L. (L.) major developed a visceral form in
which the parasite spread rapidly, resulting in death of the
mice at 6e9 weeks post-infection.3 Although the immune
response in both strains was Th1 type, the response of KO
mice was delayed with respect to that of the WT. There
was a remarkable short survival in the KO animals, which
was even shorter than the usual in BALB/c mice infected
with the same strain, indicating the high susceptibility of
the KO mice to infection. However, when the same au-
thors used a different strain of L. (L.) major named
FRIEDLIN, the results were different. Mice infected with L.
(L.) major FRIEDLIN strain exhibited partial resistance
characterized by chronic, nonhealing skin lesions without
lethality.6
Although the relevance of TNFRp55 in L. (L.) major
infection has been studied, the impact of TNFRp55 defi-
ciency on L. (L.) amazonensis infection has not been
explored. For this reason, the purpose of the present workwas to evaluate the susceptibility of TNFRp55/ B6 mice
to L. (L.) amazonensis infection compared to B6 WT mice.
To perform these studies, the TNFRp55/ mice were ob-
tained from the Max von Pettenkofer Institute, Munich,
Germany. Mice were kept under specific pathogen-free
conditions in a positive pressure cabinet (EHRET, Emmen-
dingen, Germany) and provided with sterile food and water
ad libitum. Three independent experiments were carried
out with five mice per group and all experiments involving
animals were approved by the Institutional Review Board
for Animal Experimentation of the School Medicine from the
National University of Cuyo, Mendoza, Argentina (IACUC No.
18/2013). Differences among groups were tested for sig-
nificance by two-way analysis of variance followed by
Bonferroni post-test, and by Student’s unpaired t test using
GraphPad Prism for Windows version 5.01 (GraphPad Soft-
ware, San Diego, CA, USA).
The strain of L. (L.) amazonensis (MHOM/VE/84/MEL)
used in this study was kindly provided by Dr. Miguel Angel
Basombrio, from the Experimental Pathology Institute from
the National University of Salta, Salta, Argentina. Promas-
tigotes of L. (L.) amazonensis were grown as described.7 An
inoculum of 1  106 promastigotes of L. (L.) amazonensis
per 50 mL phosphate-buffered saline was injected into the
right hind footpad in 6e8-week-old mice TNFRp55/ on a
B6 background and B6 WT mice. The course of cutaneous
lesions development was analyzed and compared during
15 weeks. As can be seen in Fig. 1A, the WT mice devel-
oped lesions at the site of infection, which peaked in size
between Week 6 and Week 10, and then steadily receded
until they disappeared at the end of the protocol. By
contrast, TNFRp55/ mice developed larger, ulcerated,
and ceraceous lesions and swollen toes. Furthermore, hind
leg retraction and hip and hinge joint deterioration were
evident. Lesions did not heal and worsened dramatically
over time, leading to loss of the infected foot. Due to the
sharp deterioration of the infected footpad in all mice of
the TNFRp55/ group, animals had to be euthanized at
Week 13 and the last two measurements of the footpad
swelling could not be completed.
For histological evaluation of the lesions induced by
inoculation of L. (L.) amazonensis in WT and TNFRp55/
mice, fragments of footpad lesions were fixed in Bouin’s
solution and embedded in paraffin. Tissue sections of
5e6 mm were cut, mounted onto glass slides, and stained
with hematoxylin/eosin. Images were taken with a Nikon
Eclipse E200 Microscope (Nikon, Tokyo, Japan) fitted with a
digital still camera Micrometric SE Premium (Nikon). His-
tological damage was assessed by observation of 10
different fields (40  magnification) of hematoxylin/eosin-
stained sections from each animal.
Histological examination of the lesions in both groups
revealed similar histopathological features at least until
Figure 1. Lesions and histological evaluation in TNFR p55/ and WT mice infected with L. (L.) amazonensis. Mice were infected
with 1  106 promastigotes of L. (L.) amazonensis in the footpads. Footpad lesion development was followed by weekly mea-
surement of footpad swelling using a digital caliper and the value for uninfected mice was subtracted from each infected footpad
to estimate lesion size (A). Macroscopic and histological aspects from TNFRp55/ and WT footpad, infected with L. (L.) ama-
zonensis (B and C) 10 weeks and (D and E) 15 weeks after infection. Histological score index of the footpad infection site from
TNFRp55/ and WT lesions (F) 10 weeks and 15 weeks after infection (n Z 3 mice per group). Data shown represent the mean
values  standard error of the mean of three independent experiments. The asterisks indicate significant differences: *p < 0.05;
**p < 0.01; and ***p < 0.001. Data are from one experiment of three performed independently. TNFRp55Z tumor necrosis factor
receptor p55; WT Z wild-type.
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terized by severe inflammation with intense tissue
destruction of the dermis and epidermis. Also, extensive
collections of vacuolated and heavily parasitized macro-
phages were observed. Amastigote forms were attached to
the wall of the parasitophorous vacuoles and a large num-
ber of parasitized macrophages and extensive areas of ne-
crosis were seen. In these areas of necrosis, free
amastigotes were seen among inflammatory cells. Occa-
sionally, areas of necrosis were infiltrated by granulocytes,
giving rise to micro-abscesses (Fig. 1A and C).
Fifteen weeks after infection, the histological exami-
nation of the lesions from the TNFRp55/ group showed a
large number of inflammatory cells with the same histo-
pathological characteristics described above (Fig. 1D),
whereas lesions from the WT mice (Fig. 1E) showed few
inflammatory cells. Histological changes in the lesions
were semiquantitatively graded based on the criteria
described by Coˆrtes et al.8 The histopathological scoring
and grading system used to evaluate the degree of
inflammation was as follows: 0: none; 1: slight infiltration
of inflammatory cells; 2: moderate infiltration; 3: severe
infiltration.8 The total score was defined as the sum of all
the scores. Each slide was scored by two independent
observers and the average score was used. A significant
decrease in the histological score index resulted from the
analysis of the degree of inflammation in the footpad
lesion of the WT group compared to those of the
TNFRp55/ group (Fig. 1F).
The splenic index was used as an indicator of disease
progression to evaluate the degree of susceptibility of both
experimental groups to L. (L.) amazonensis infection. Mice
were weighed and sacrificed by cervical dislocation. The
spleen was removed from sacrificed animals and weighed in
a digital precision balance. This index was determined ac-
cording to the formula9:
Splenic indexZspleen weight=whole body weight 100:
At 10 weeks post-infection, the splenic index was similar
in both groups. However, at Week 15, the splenic index of
the WT mice increased slightly, whereas that of theTable 1 Splenic indexes generated by the infection of L.
(L.) amazonensis in WT and TNFRp55/ micea
WT TNFRp55/
Mean Standard error Mean Standard error
Week 10 0.54 0.02 0.47* 0.02
Week 15 0.86 0.09 2.01** 0.31
a Mice were infected with L .(L.) amazonensis in the footpad
(1  106) and after 10 weeks and 15 weeks of infection, animals
were weighed, sacrificed, and the spleen collected. The splenic
index was determined. Results represent the mean of five ani-
mals for each experimental group. Data shown represent the
mean  standard error of the mean of three independent
experiments.
*p Z 0.108 Student’s t test.
**p Z 0.012 Student’s t test.
TNFRp55 Z tumor necrosis factor receptor p55; WT Z wild-
type.TNFRp55/ mice increased fivefold (Table 1). This result
shows that TNFRp55/ mice, experimentally infected with
L. (L.) amazonensis, developed massive splenomegaly,
which is a hallmark of visceral leishmaniasis. It is known
that infection with L. (L.) amazonensis may be associated
with many different clinical presentations including
visceralization.10
The role of TNF in promoting resistance to intracellular
parasitic pathogens such as L. (L.) major has been investi-
gated in a range of experimental models,3e6 but the impact
of TNFRp55 deficiency on L. (L.) amazonensis infection has
not been explored. In this work, we have shown that
TNFRp55 plays a key role in the protection against leish-
maniasis induced by L. (L.) amazonensis infection in B6
mice. These results are similar to those reported by Oliveira
et al,4 using infection of a similar mouse model with L. (L.)
major. In both cases, the TNFRp55/mice failed to resolve
lesions that were characterized by intense infiltration of
inflammatory cells.
Taken together, our results demonstrate that TNFRp55
plays a critical role in the control of L. (L.) amazonensis
pathogenicity. These results indicate that TNFRp55 plays a
key role (1) in the clearance of the inflammatory infiltrate
on the infected footpad; (2) in the development of
splenomegaly associated with infection; and (3) in the
healing process of the footpad lesions. These are the first
data demonstrating that TNF is essential for the in vivo
control of L. (L.) amazonensis infection.
To elucidate the mechanisms by which TNF exerts its
protective role in this model, we are presently studying the
consequences of TNF signaling on several different param-
eters of the immune response in infected mice.
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